Track & Trace

Counterfeit drugs and diversion risk lives, undermine revenues and threaten company reputations. Supply chain security and the ability to authenticate the e-Pedigree, or life history, of a product is an essential part of the battle against fake drugs. It is also increasingly important in combating product diversion, where legitimate products are diverted from one market to another, with implications for licensing obligations and distribution agreements as well as for revenues. An estimated 5% of all drugs sold worldwide – and the number is continuously growing – are counterfeits and US$ 40bn worth of product is “lost in the supply chain “every year.

In a world where the online trade of fake drugs is all too visible, where there is a growing incidence of fake products reaching licensed distributors and pharmacies and where a large proportion of counterfeit medicine seizures are of “commercial size, “companies need to be sure they are doing all they can to secure their supply chains and prove product authenticity.

The failure of a company to demonstrate that it is doing all it reasonably can to secure and authenticate its products could fatally damage its brand and reputation. They cannot risk a situation where lives are at risk and they have failed to implement measures that other companies,whether inside or outside of the sector,have adopted. Authorities around the world have started to regulate measures to enforce track and trace for drugs based on serialization.


The SS DATACODE serialization solution enables your company to fulfill existing and upcoming legal global requirements and to protect your brand, your customers, and your revenue. The gains from such technology go even further. They also deliver better supply chain transparency and better optimization and control of supply infrastructure, allowing for added business agility and profitability.

Serialization is the key concept in Pharma industry against counterfeiting by providing the uniqueness of each drug unit, while preserving patient safety and profitability of manufacturers.

Some Statistics on Counterfeit Drugs


  • An estimated 10%–30% of medicines sold in developing countries are counterfeit.
  • The value of the counterfeit drug market annually: $200 billion.
  • Internet sales of counterfeit drugs account for $75 billion of the total market.
  • A 10 day crackdown against counterfeit drugs coordinated by Interpol in May 11-21, 2014 led to 8.4 million doses of counterfeit drugs being confiscated.
  • 237 people were arrested worldwide and 10,603 websites that were selling counterfeit medicines were shut down in 2014.
  • An estimated 80% of the counterfeit drugs that are consumed in the United States come from overseas.
  • Most of the counterfeit drugs that are made have been manufactured in either India or China.
  • The WHO also estimates that between 1% and 10% of drugs sold around the world are counterfeits, but it may be as high as 50% in some countries.
  • The prescription drug market is vast and lucrative – up to $900 billion worldwide annually.
  • About 85% of the world pharmaceutical market is in developed world.
  • WHO estimates that 16% of counterfeit drugs contain the wrong ingredients, while 17% contain the wrong levels of necessary ingredients
  • More than 30% of the counterfeit drugs that are available today don’t contain any active ingredients whatsoever.
  • A recent survey of seven African countries by WHO found that between 20% and 90% of all anti-malarial failed quality testing.
©2019SSDC. All Rights Reserved